Analyst ratings, especially from reputable firms like BTIG, can significantly influence investor sentiment and stock prices. A Buy rating combined with a substantial price target suggests a positive outlook for Theravance Biopharma, potentially leading to increased investor interest and a rise in stock price in the short term.